5.62
Precedente Chiudi:
$5.29
Aprire:
$5.35
Volume 24 ore:
983.18K
Relative Volume:
1.06
Capitalizzazione di mercato:
$335.65M
Reddito:
-
Utile/perdita netta:
$-96.66M
Rapporto P/E:
-2.614
EPS:
-2.15
Flusso di cassa netto:
$-83.73M
1 W Prestazione:
+14.46%
1M Prestazione:
+68.77%
6M Prestazione:
-51.64%
1 anno Prestazione:
-44.19%
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Nome
Olema Pharmaceuticals Inc
Settore
Industria
Telefono
(415) 651-3316
Indirizzo
780 BRANNAN STREET, SAN FRANCISCO
Confronta OLMA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
OLMA
Olema Pharmaceuticals Inc
|
5.62 | 335.65M | 0 | -96.66M | -83.73M | -2.15 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
501.15 | 126.96B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
605.61 | 65.06B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ARGX
Argen X Se Adr
|
649.67 | 37.54B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
259.39 | 32.56B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
255.77 | 26.40B | 3.81B | -644.79M | -669.77M | -6.24 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-04-02 | Iniziato | Goldman | Buy |
2024-01-30 | Iniziato | Citigroup | Buy |
2023-07-21 | Iniziato | Oppenheimer | Outperform |
2023-05-05 | Iniziato | CapitalOne | Overweight |
2023-02-22 | Iniziato | Credit Suisse | Outperform |
2022-07-06 | Ripresa | Canaccord Genuity | Buy |
2022-06-09 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
2022-02-28 | Iniziato | H.C. Wainwright | Neutral |
2021-12-07 | Ripresa | Cowen | Outperform |
2020-12-14 | Iniziato | Canaccord Genuity | Buy |
2020-12-14 | Iniziato | Cowen | Outperform |
2020-12-14 | Iniziato | JP Morgan | Overweight |
2020-12-14 | Iniziato | Jefferies | Buy |
Mostra tutto
Olema Pharmaceuticals Inc Borsa (OLMA) Ultime notizie
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | OLMA Stock News - GuruFocus
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Breast Cancer Drug Developer Olema Awards 104,400 Stock Options to Key New Hires - Stock Titan
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by Legal & General Group Plc - Defense World
A look into Olema Pharmaceuticals Inc (OLMA)’s deeper side - Sete News
Renaissance Technologies LLC Has $917,000 Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Metastatic HR+/HER2- Breast Cancer Market—The Road Ahead for Targeted Therapies and Personalized Medicine | DelveInsight - GlobeNewswire Inc.
Can you now get a good deal on Olema Pharmaceuticals Inc’s shares? - uspostnews.com
Olema Pharmaceuticals' (OLMA) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
Walleye Capital LLC Invests $391,000 in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Financial Snapshot: Analyzing Olema Pharmaceuticals Inc (OLMA)’s Key Ratio Metrics - DWinneX
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by JPMorgan Chase & Co. - Defense World
Olema Pharmaceuticals’ (OLMA) Buy Rating Reaffirmed at HC Wainwright - Defense World
Market Recap Check: Olema Pharmaceuticals Inc (OLMA)’s Negative Finish at 3.76, Up/Down -8.52 - DWinneX
Silverarc Capital Management LLC Reduces Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Avoro Capital Advisors LLC Takes $9.63 Million Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Geode Capital Management LLC Decreases Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Bain Capital Life Sciences Investors LLC Invests $43.55 Million in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals Says OP-3136 Molecule Shows Anti-Tumor Activity in Preclinical Models - marketscreener.com
Olema Oncology Announces New Preclinical Data for OP-3136 - GlobeNewswire
Cancer Breakthrough: New Drug OP-3136 Achieves 28-Day Tumor Regression in Multiple Cancer Types - Stock Titan
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Short Interest Update - MarketBeat
Financial Analysis: Olema Pharmaceuticals Inc (OLMA)’s Ratios Unveil Key Insights - DWinneX
Wall Street Analysts Think Olema Pharmaceuticals (OLMA) Could Surge 433.13%: Read This Before Placing a Bet - Yahoo Finance
Olema Pharmaceuticals Inc (OLMA)’s results reveal risk - uspostnews.com
Alliancebernstein L.P. Has $1.83 Million Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Vanguard Group Inc. Has $15.65 Million Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals Inc (OLMA) Stock: From Low to High in 52 Weeks - investchronicle.com
Franklin Resources Inc. Has $1.60 Million Stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Vanguard Group Inc. Grows Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Alliancebernstein L.P. Has $1.83 Million Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
American Century Companies Inc. Reduces Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Wellington Management Group LLP Boosts Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
KLP Kapitalforvaltning AS Takes Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
OLMA’s Stock Market Adventure: -41.51% YTD Growth Amidst Volatility - investchronicle.com
After Plunging -30.16% in 4 Weeks, Here's Why the Trend Might Reverse for Olema Pharmaceuticals (OLMA) - Yahoo Finance
Wellington Management Group LLP Has $8.84 Million Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - The AM Reporter
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Bought by Schroder Investment Management Group - MarketBeat
Olema Pharmaceuticals Inc Azioni (OLMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):